Mineralys Therapeutics, a Radnor biopharmaceutical company is hoping to raise $100 million to develop a new high blood pressure treatment, writes John George for Philadelphia…

It is no secret that the digital age has created a greater number of alternative investment opportunities, perhaps most notably cryptocurrency.

However, other alternative investments…

It is well-documented how recessions in the past proved very costly for many investors. Some saw their investments in stocks and real estate plummet…